Cerebras Systems Inc. stocks have been trading up by 8.25 percent amid strong enthusiasm for its latest AI chip advancements.
Click Here for a Millionaire's POV on Trading CBRS
SUBSCRIBE FOR ALERTSJOIN 50,000+ ACTIVE TRADERS
What Traders Need To Know
- Q1 revenue jumped to $193.4M and topped expectations, but an EPS miss drove a sharp 16–17% drop as traders hit the sell button on profit concerns.
- Wedbush reaffirmed an Outperform call on Cerebras Systems Inc. ahead of Q1, citing early AI accelerator share gains and upside from AI inference growth and a future WSE-4 chip.
- An expanded Flex manufacturing deal aims to lift CS-3 AI supercomputer capacity roughly sevenfold at a Milpitas, California facility through 2026, and shares spiked about 10% on the news.
- A planned build-out to 200MW of AI infrastructure capacity in Europe by late 2027, supporting OpenAI workloads, positions Cerebras Systems Inc. as both a chip and infrastructure player.
- Upcoming earnings remain a key volatility catalyst for CBRS within a broadly constructive S&P 500 earnings backdrop.
Weekly Update Jul 06 – Jul 10, 2026: On Friday, July 10, 2026 Cerebras Systems Inc. stock [NASDAQ: CBRS] is trending up by 8.25%! Discover the key drivers behind this movement as well as our expert analysis in the detailed breakdown below.
Technology industry expert:
Analyst sentiment – positive
Cerebras (CBRS) is an early-stage AI accelerator vendor with rapid topline growth but still-unproven earnings power. Q1 revenue of $193.4M and gross profit of $86.2M show solid demand, but operating loss of $15.0M and pretax margin of roughly -6.5% underscore a model not yet at scale efficiency. Free cash flow was -$120M despite positive operating cash flow, reflecting heavy capex. The balance sheet is unconventional: negative common equity, large preferred securities, but strong liquidity with ~$1.7B cash and modest net debt.
Technically, CBRS is in a strong short-term uptrend, with closes rising from $181 to $214 over five sessions and higher highs/lows each day. The recent surge toward $215 followed news-driven volume spikes, with intraday 5-minute candles showing persistent dip-buying and shallow pullbacks, confirming aggressive accumulation. First actionable level is $200–201: prior breakout area and now key support. I would buy pullbacks toward $201 with a stop near $189 (last swing low) and target a retest of the $230 area.
More Breaking News
- FBRX Stock Soars As FB102 Vitiligo Data Ignite Biotech Momentum
- META Stock Jumps As AI Cloud And Chip Ambitions Accelerate
- PMA Stock Slides As Leverage And Volatility Test Traders
- FLNC Stock Slides As AI Battery Demand Story Heats Up
Fundamentally, CBRS screens better than many early-stage AI peers on revenue momentum but worse on earnings quality versus the broader Technology and Semiconductors & Equipment indices, which are already profit-generating. Near-term catalysts are strong: Flex manufacturing ramp (7x CS-3 capacity), 200MW European AI footprint supporting OpenAI, and upcoming quarters where wafer supply and WSE-4 visibility will drive sentiment. With high volatility, I see an attractive but speculative long, with support at $200 and resistance near $235–240.
Quick Financial Overview
Cerebras Systems Inc. sits in a classic high-growth, high-spend phase. Q1 revenue of $193.4M more than doubled year over year and beat consensus, but the company still posted a net loss of about $14.0M and a pretax margin near -6.5%. Research and development spending of roughly $75.5M shows how aggressively Cerebras is leaning into AI hardware and systems, while cash and short-term investments above $2.2B provide a sizable liquidity cushion.
The balance sheet is unusual for a growth name: common equity stands around -$195M due to heavy accumulated losses and preferred securities, while enterprise value is roughly $43.37B. Return on assets is negative at about -0.28, but a reported 1-year return on invested capital of 12.97 suggests that recent deployments may be starting to earn their keep. Operating cash flow is just positive at $12.3M, with free cash flow still negative near -$119.6M after sizable capital expenditures.
On the tape, CBRS has recovered from the late-June earnings selloff. The weekly data show a move from the mid-$170s back above $210, with the latest close near $214 suggesting bulls are in control after the Flex and Europe expansion headlines. Intraday, the stock opened around the high-$190s, tested $191–$199 premarket, then trended higher all day, pushing through $210 by midday and grinding to the $214–$215 zone into the close. That intraday pattern – early volatility, then steady higher lows – is what you want to see when a name is being accumulated after good news.
Conclusion
This is stock news, not investment advice. StocksToTrade News delivers real-time stock market updates tailored to highlight the key catalysts driving short-term price movements. Our coverage is designed for active traders and investors who thrive in fast-moving markets, with a focus on volatile sectors like penny stocks, AI stocks, Robinhood stocks and other momentum plays. From earnings reports and FDA approvals to mergers, new contracts, and unusual trading volume, we break down the events that can spark significant price action.
Looking to level up your trading game? Explore StocksToTrade, the ultimate platform for traders. With powerful tools designed for swing and day trading, integrated news scanning, and even social media monitoring, StocksToTrade keeps you one step ahead.
Check out our quick startup guide for new traders!
- How to Read Stock Charts: A Guide for Beginners
- Trading Plan: 6 Steps to Create One
- How To Create a Stock Watchlist
Ready to build your watchlists? Check out these curated lists:
Once your watchlist is set, take the next step and trade with confidence using StocksToTrade’s robust platform. Don’t miss out — grab your 14-day trial for just $7 and experience the edge you need to thrive in today’s fast-paced markets.